Тревога и тревожные расстройства в практике кардиолога
Аннотация
В обзоре приведены данные о распространенности, клинической картине и клиническом значении тревожных расстройств (ТР) в практике кардиолога; рассматриваются проблемы дифференциальной диагностики соматических симптомов патологической тревоги и симптомов сердечно-сосудистых заболеваний; описаны принципы скрининга ТР у кардиологических больных. Проанализированы результаты клинических исследований роли ТР в развитии ишемической болезни сердца и артериальной гипертонии и повышения риска сердечно-сосудистой смертности у лиц с патологической тревогой, рассматриваются возможные патогенетические механизмы, опосредующие эту связь. Даны практические рекомендации по лечению ТР у кардиологических больных в соответствии с международным консенсусом по тревоге в кардиологии.
Об авторе
Е. Г. Старостина
Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского. Москва
Россия
Россия
Список литературы
1. Бобров А.Е., Белянчикова М.А. Распространенность и структура психических расстройств в семьях женщин, страдающих пороками сердца (лонгитудинальное исследование). Ж невропатол психиат 1999; 99: 52-5.
2. Оганов РГ, Ольбинская ЛИ, Смулевич АБ. и др. Депрессия в общемедицинской практике. Результаты программы КОМПАС. Кардиология 2004; 1: 48-54.
3. Смулевич А.Б, Сыркин А.Л., Дробижев М.Ю. и др. Терапия кардионевротических расстройств в общетерапевтической практике: опыт применения атаракса. Клин мед 1999; 1: 43-6.
4. Старостина Е.Г. Генерализованное тревожное расстройство и симптомы тревоги в общемедицинской практике. РМЖ 2004; 12(22): 1277- 83.
5. Старостина Е.Г. Ожирение как психосоматическое заболевание. Ожир метабол 2005; 3: 18-23.
6. Чуркин А.А., Мартюшов А.Н. Краткое руководство по использованию МКБ-10 в психиатрии и наркологии. Москва «Триада-Х» 1999.
7. Ahern DK, Gorkin L, Anderson JL, et al. for the CAPS Investigators. Biobehavioural variables and mortality or cardiac arrest in the Cardiac Arrhythmias Pilot Study (CAPS). Am J Cardiol 1990; 66: 59-62.
8. Albert CM, Chae CU. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005; 111: 480-7.
9. Allgulander C, Lavori PW. Excess mortality among 3302 patients with «pure» anxiety neurosis. Arch Gen Psychiatry 1991; 48: 599-692.
10. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on depression, anxiety and cardiovascular disease. J Clin Psychiatry 2001; 62: 24-47.
11. Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on generalized anxiety disorder from the International Consensus group on depression and anxiety. J Clin Psychiatry 2001; 62 (Suppl. 11): 53-8.
12. Bankier B, Januzzi JL, Littman AB. The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med 2004;66(5): 645-50.
13. Barger SD, Sydeman SJ. Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder? J Affect Disord 2005; 88(1): 87-91.
14. Benninghoven D, Kaduk A, Wigand U, et al. Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function? Psychother Psychosom 2006; 75(1): 56-61.
15. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Reviews 2001; 2: 73-86.
16. Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987; 101: 343-62.
17. Cailey WE. Diagnosing the cause of chest pain. Am Fam Physician 2005; 72: 2012-21.
18. Culpepper L. Generalized anxiety disorder in primary care: emerging issues in management and treatment. J Clin Psychiatry 2002; 63 (Suppl. 8): 35-41.
19. Curtis BM, O’Keefe JH. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002; 77: 45-54.
20. Davies SJ, Ghahramani P, Jackson PR, et al. Association of panic disorder and panic attacks with hypertension. Am J Med 1999; 107(4): 310-6.
21. Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998; 97: 167-73.
22. Eaker ED, Sullivan EM, Kelly-Hayes M, et al. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Medicine 2005; 67: 692-6.
23. Ehlers A, Mayou R, Sprigings DC, et al. Psychological and perceptual factors associated with arrhythmias and benign palpitations. Psychosom Med 2000; 62: 693-702.
24. Figgit DP, McClelan KJ. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Drugs 2000; 60(4): 925-54.
25. Fleet R, Lesperance R. Myocardial perfusion study of panic attacks in patients with coronary artery disease. Am J Cardiol 2005; 96(8): 1064-8.
26. Fontaine R, Boysvert D. Psychophysiological disorders in anxious patients: hypertension and hypotension. Psychother Psychosom 1982; 38: 165-72.
27. Frasure-Smith N, Lespоrance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 1995; 14: 388-98.
28. Frenkel YM, Kindler S, Melmed RN. Differences in cognitions during chest pain of patients with panic disorder and ischemic heart disease. Depress Anxiety 1996-97; 4(5): 217-22.
29. Friedman BH, Thayer JF, Borkovec TD, et al. Autonomic characteristics of nonclinical panic and blood phobia. Biol Psychiatry 1993; 34: 298-310.
30. Godemann F, Butter C, Lampe F, et al. Panic disorders and agoraphobia: side effects of treatment with an implantable cardioverter/defibrillator. Clin Cardiol 2004; 27(6): 321-6.
31. Gullette EC, Blumenthal JA, Babyak M, et al. Effects of mental stress on myocardial ischemia during daily life. JAMA 1997; 277: 1521-6.
32. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischemic heart disease. BMJ 1987; 295: 297-9.
33. Hawort JE, Moniz-Cook E, Clark AL, et al. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail 2005; 7(5): 803-8.
34. Hayword C, Taylor CB. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry 1992; 142: 376-8.
35. Hаrter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and medical illness. Eur Arch Psychiatry Clin Neurosci 2003; 253: 313-20.
36. Hemingway H, Marmot M. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999; 318: 1460-7.
37. Huffman JC, Pollack MH. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics 2003; 44(3): 222-36.
38. Huffman JC, Stern TA. The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med 2003; 25(4): 427-37.
39. Jiang W, Kuchibhatla M, Cuffe MS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004; 110: 3452-6.
40. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Arch Fam Med 1997; 6: 43-9.
41. Kane FJ Jr, Harper RG, Wittels E. Angina as a symptom of psychiatric illness. South Med J 1988; 81(11): 1412-6.
42. Kane FJ Jr, Wittels E, Harper RG. Chest pain and anxiety disorder. Tex Med 1990; 86(7): 104-10.
43. Kanel R, Kudielka BM. Hypercoagulability in working men and women with high levels of panic-like anxiety. Psychother Psychosom 2004; 73(6): 353-60.
44. Katerndahl D. Panic and plaques: panic disorder and coronary artery disease in patients with chest pain. J Am Board Fam Pract 2004; 17(2): 114-26.
45. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic anxiety and coronary artery heart disease in men. Circulation 1994; 89: 1995-7.
46. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994; 90(5): 2225-9.
47. Kawachi I, Sparrow D, Vokonas PS, et al. Decreased heart rate variability in men with phobic anxiety (Data from the Normative Aging Study). Am J Cardiol 1995; 75: 882-5.
48. Keogh E, Hamid R, Hamid S, et al. Investigating the effect of anxiety sensitivity, gender and negative interpretative bias on the perception of chest pain. Pain 2004; 111(1-2): 209-17.
49. Kubzansky LD, Kawachi I, Spiro A, et al. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997; 95: 818-24.
50. Kubzansky LD, Kawachi I, Weiss ST, et al. Anxiety and coronary heart disease: a synthesis of epidemiological, psychological and experimental evidence. Ann Behav Med 1998; 20: 47 58.
51. Lader M, Scotto JC. A multicentre, double blind comparison of hydroxizine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology 1998; 139: 402-6.
52. Lambert EA, Thompson G, Schlaich M, et al. Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens 2002; (12): 2445-51.
53. Lane D, Carroll D, Ring C, et al. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63: 221-30.
54. Lane D, Carrol D, Ring C, et al. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol 2002; 7(Pt 1): 11-21.
55. Lane D, Carrol D, Lip G. Anxiety, depression, and prognosis after myocardial infarction. Is there a causal association? JACC 2003; 42: 1808-10.
56. Lavie C, Milani R. Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol 2004; 93: 336-9.
57. Leibing E, Schunemann I. Psychiatric disorder or coronary heart disease? Psychological test data and ICD-10 diagnoses in patients undergoing coronary angiography. Psychother Psychosom Med Psychol 1998; 48(1): 30-6.
58. Linden W, Stossel C, Maurice J. Psychosocial interventions in patients with coronary artery disease: a meta analysis. Arch Intern Med 1996; 156: 745 52.
59. Llorca PM, Spadone C, Sol O, et al. Efficacy and safety of hydroxizine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry 2002; 63: 1020-7.
60. Marciniak M, Lage MJ, Landbloom RP, et al. Medical and productivity costs of anxiety disorders: case control study. Depression and Anxiety 2004; 19: 112-20.
61. Massana J, Lopez-Risueno JA. Subtyping of panic disorder patients with bradycardia. Eur Psychiatry 2001; 16(2): 109-14.
62. Mayou R, Gill D, Thompson DR, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212-9.
63. McLaughlin T, Geissler EC, Wan GJ. Comorbidities and associated treatment charges in patients with anxiety disorders. Pharmacotherapy 2003; 23(10): 1251-6.
64. Morris A, Baker B. Prevalence of panic disorder in cardiac outpatients. Can J Psychiatry 1997; 42(2): 185-90.
65. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996; 58: 395-401.
66. Moser DK, Dracup K, McKinley S, et al. An international perspective on gender differences in anxiety early after acute myocardial infarction. Psychosom Med 2003; 65: 511-6.
67. O’Brien JL, Moser DK, Riegel B, et al. Comparison of anxiety assessments between clinicians and patients with acute myocardial infarction in cardiac critical care units. Am J Crit Care 2001; 10(2): 97-103.
68. Paterniti S, Alperovich A, Ducimetiere P, et al. Anxiety, but not depression is associated with elevated blood pressure in a community group of French elderly. Psychosom Med 1999; 61: 77-83.
69. Paterniti S, Zureik M. Sustained anxiety and 4-year progression of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21(1): 136-41.
70. Peters A, Schweiger U, Pellerin L, et al. The selfish brain: competition for energy resources. Neurosci Biobehav Rev 2004; 28(2): 143-80.
71. Pollack MH, Allgulander C, Bandelow B, et al. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr 2003; 8(Suppl 1):17-30.
72. Pott SG, Bass CM. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: a longterm follow-up study. Psychol Med 1995; 25(2): 339-47.
73. Raikkonen K, Matthews KA, Kuller LH. Trajectory of psychological risk and incident hypertension in middle-aged women. Hypertension 2001; 38: 798-802.
74. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-217.
75. Rutledge T, Reis SE, Olson M, et al. History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. JACC 2001; 37(3): 780-5.
76. Simon J, Lecrubier Y, Ustun TB. Somatic symptoms and psychiatric disorder: an international primary care study. Rev Contemp Pharmacotherapy 1996; 7: 279-85.
77. Sloan RP, Shapiro PA, Bagiella E, et al. Cardiac autonomic control buffers blood pressure variability responses to challenge: a psychophysiologic model of coronary artery disease. Psychosom Med 1999; 61: 58-68.
78. Stein MB, Roy-Byrne PP, McQuaid JR, et al. Development of brief diagnostic screen for panic disorder in primary care. Psychosom Med 1999; 61: 359-64.
79. Strik JJ, Denollet J. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. JACC 2003; 42(10): 1801-7.
80. Sullivan GM, Kent JM, Kleber M, et al. Effects of hyperventilation on heart rate and QT variability in panic disorder pre and post-treatment. Psychiatry Res 2004; 125(1): 29-39.
81. Tallis F, Davey GCL, Capuzzo N. The phenomenology of nonpathological worry: a preliminary investigation. In: Davey G, Tallis F, eds. Worrying: perspectives on theory, assessment, and treatment. New York, NY: John Wiley & Sons 1994; 62-89.
82. Tanabe Y, Harada H. 123I-Metaiodobenzylguanidine myocardial scintigraphy in panic disorder. J Nucl Med 2004; 45(8): 1305-8.
83. Thayer JF, Friedman BH, Borkovec TD. Autonomic characteristics of generalized anxiety disorder and worry. Biol Psychiatry 1996; 39(4): 255-66.
84. Virtanen R, Jula A, Salminen JK, et al. Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-tobeat blood pressure variability. Psychosom Med 2003; 65: 751-6.
85. Watkins SS, Grossman P. Anxiety and vagal control of heart rate. Psychosom Med 1998; 60(4): 498-502.
86. Weissman MM, Markowitz JS, Ouelette R, et al. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry 1990; 147: 1504-8.
87. Wells KB, Golding JM, Burnham NA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988; 145(8): 976-81.
88. Wittchen HU, Beesdo K, Bittner A, et al. Depressive episodesevidence for a causal role of primary anxiety disorders? Eur Psychiatry 2003; 18(8): 384-93.
89. Wyszynski A, Schwartz M, Rubenstein B, et al. The patient with cardiovascular disease. In: Manual of psychiatric care for the medically ill. 1st ed. American Psychiatric Publishing, Inc. Washington 2004; 49-67.
90. Yan LL, Kiang L, Matthews KA, et al. Psychosocial factors and risk of hypertension: the coronary artery risk development in young adults (CARDIA) Study. JAMA 2003; 290: 2138-48.
91. Yeragani VK, Pohl R, Berger R, et al. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1993; 46: 89-103.
92. Yeragani VK, Tancer M, Uhde T. Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res 2003; 121(2): 185-96.
93. Zvolensky MJ, Eifert GH, Feldner MT, et al. Heart-focused anxiety and chest pain in postangiography medical patients. J Behav Med 2003; 26(3): 197-209.
Рецензия
Для цитирования:
Старостина Е.Г. Тревога и тревожные расстройства в практике кардиолога. Кардиоваскулярная терапия и профилактика. 2006;5(3):111-120.
For citation:
Starostina E.G. Anxiety and anxiety disorders in cardiology practice. Cardiovascular Therapy and Prevention. 2006;5(3):111-120. (In Russ.)
Просмотров:
1220
Послать статью по эл. почте 
